NVCR Q4 2024 Earnings — NovoCure Limited Revenue & Financial Results | Market Cap Arena

NVCRNovoCure Limited

$1B

Q4 2024 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$161M+20.5% YoY

Gross Profit

$128M79.2% margin

Operating Income

-$63M-39.3% margin

Net Income

-$66M-40.9% margin

EPS (Diluted)

$-0.61

QoQ Revenue Growth

+4.0%

Cash Flow

Operating Cash Flow

-$3M

Free Cash Flow

-$12M

Stock-Based Comp.

$63M

Balance Sheet

Total Assets

$1.2B

Total Liabilities

$881M

Stockholders' Equity

$360M

Cash & Equivalents

$164M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$161M	$134M	+20.5%
Gross Profit	$128M	$101M	+26.2%
Operating Income	-$63M	-$52M	-22.4%
Net Income	-$66M	-$47M	-40.0%

Geographic Segments

UNITED STATES

$107M50%

International Markets

$52M24%

FRANCE

$26M12%

GERMANY

$17M8%

JAPAN

$9M4%

CHINA

$2M1%